GNECCHI, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 5.514
AS - Asia 4.438
EU - Europa 3.489
SA - Sud America 613
AF - Africa 181
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 14.255
Nazione #
US - Stati Uniti d'America 5.361
CN - Cina 1.971
SG - Singapore 1.043
IE - Irlanda 824
HK - Hong Kong 487
IT - Italia 481
BR - Brasile 466
DE - Germania 434
RU - Federazione Russa 431
VN - Vietnam 401
FI - Finlandia 377
UA - Ucraina 237
FR - Francia 206
GB - Regno Unito 138
IN - India 132
SE - Svezia 121
ZA - Sudafrica 109
CA - Canada 85
JP - Giappone 56
AR - Argentina 53
MX - Messico 49
BD - Bangladesh 48
AT - Austria 47
TR - Turchia 40
PL - Polonia 38
ID - Indonesia 37
BE - Belgio 33
NL - Olanda 32
IQ - Iraq 30
ES - Italia 27
EC - Ecuador 25
MY - Malesia 22
PH - Filippine 21
CO - Colombia 19
PK - Pakistan 19
SA - Arabia Saudita 18
VE - Venezuela 17
KE - Kenya 16
AE - Emirati Arabi Uniti 15
JO - Giordania 14
UZ - Uzbekistan 12
MA - Marocco 11
MU - Mauritius 11
LT - Lituania 10
AU - Australia 9
CL - Cile 9
AL - Albania 8
EG - Egitto 8
PE - Perù 8
PY - Paraguay 8
TN - Tunisia 8
CH - Svizzera 7
AZ - Azerbaigian 6
BO - Bolivia 6
CZ - Repubblica Ceca 6
IL - Israele 6
IR - Iran 6
KR - Corea 6
NP - Nepal 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
EU - Europa 5
KG - Kirghizistan 5
PT - Portogallo 5
SN - Senegal 5
KZ - Kazakistan 4
LB - Libano 4
OM - Oman 4
PA - Panama 4
AO - Angola 3
BY - Bielorussia 3
CM - Camerun 3
CR - Costa Rica 3
HR - Croazia 3
JM - Giamaica 3
KW - Kuwait 3
PS - Palestinian Territory 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
GI - Gibilterra 2
LV - Lettonia 2
MK - Macedonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
TW - Taiwan 2
BB - Barbados 1
ET - Etiopia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
Totale 14.243
Città #
Dublin 824
Chandler 686
Singapore 583
San Jose 536
Ashburn 503
Hong Kong 474
Beijing 420
Dallas 408
Nanjing 363
Jacksonville 319
Boardman 198
New York 193
Helsinki 166
Los Angeles 159
Wilmington 147
Princeton 145
Ho Chi Minh City 136
Lauterbourg 136
Lawrence 134
Nanchang 132
Munich 122
Hanoi 104
Changsha 103
Hebei 103
Pavia 101
Johannesburg 96
Shenyang 95
Medford 92
Jiaxing 86
Shanghai 85
Ann Arbor 76
Moscow 76
Hangzhou 70
Buffalo 66
São Paulo 55
Redondo Beach 54
Nuremberg 53
Milan 51
Tokyo 49
Tianjin 45
Turku 43
Orem 42
Toronto 39
Frankfurt am Main 35
Warsaw 34
Santa Clara 29
Brussels 28
Woodbridge 28
Chennai 27
The Dalles 25
Brooklyn 23
Denver 23
Montreal 23
Norwalk 23
Dearborn 22
Falls Church 22
Guangzhou 21
London 20
Seattle 20
Fairfield 19
Boston 18
Falkenstein 18
Rio de Janeiro 18
Rome 18
Vienna 18
Atlanta 17
Belo Horizonte 17
Da Nang 17
Haiphong 17
Mexico City 17
Mumbai 16
Amsterdam 15
Council Bluffs 15
Chicago 14
Nairobi 14
Verona 14
Washington 14
Ankara 13
Columbus 13
Zhengzhou 13
Amman 12
Baghdad 12
Piscataway 12
Poplar 12
San Francisco 12
Stockholm 12
Houston 11
Manchester 11
Phoenix 11
Caracas 10
Chieti 10
Jakarta 10
New Delhi 10
Quito 10
Redwood City 10
Tashkent 10
Des Moines 9
Lahore 9
Brasília 8
Campinas 8
Totale 9.315
Nome #
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 245
Cellule staminali mesenchimali fetali isolate da placenta esercitano effetti paracrini cardioprotettivi. 203
Allogeneic Lethally Irradiated Cord Blood Mononuclear Cells in No-Option Critical Limb Ischemia: A “Box of Rain” 167
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 158
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 152
Concomitant overexpression of IGF1 and BMP2 in mesenchymal stem cells mediates cytoprotection through both autocrine and paracrine activation of Akt, Erk1/2 and SMAD1/5/8 pathways. 151
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 130
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain 129
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 129
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 129
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 128
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 127
Improved transduction efficiency of human amniotic mesenchymal stem cells using optimized lentiviral vectors 125
Mesenchymal stem cell therapy for heart disease. 122
Combined transcriptomic and proteomic approach identifies several putative paracrine factors of fetal mesenchymal stem cells. 121
Adult stem cell-based therapy for the heart 120
Novel experimental protocol to study area at risk, infarct size, immunohistochemistry and tissue protein content on the same rodent heart. 120
Paracrine mechanisms of mesenchymal stem cells in tissue repair 120
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 120
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 120
Identificazione di fattori paracrini e cardioprotettivi mediante analisi combinata del trascrittoma e del proteoma di cellule staminali mesenchimali fetali. 118
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 117
Donor Age Negatively Influences Cytoprotective but Not Proangiogenic Paracrine Properties of Human Mesenchymal Stem Cells. 117
Testing the paracrine properties of human mesenchymal stem cells using conditioned medium 116
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 115
Identification of cardioprotective factors produced by fetal mesenchymal stem cells through a combined transcriptomic and proteomic approach. 114
Impiego di cellule staminali mesenchimali in cardiologia. 114
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 114
Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 113
Studio pilota sull'impiego di cellule CD133+ immunoselezionate per il trattamento di vasculopatie periferiche. 113
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 113
Cord blood derived endothelial progenitor cells: time dependent in vitro generation capacity. 112
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 112
Elevated serum uric acid is a predictor of contrast associated acute kidney injury in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 111
Human fetal mesenchymal stem cells protect cardiac myocytes against hypoxia/reoxygenation injury 111
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 111
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 111
Enhancing the cardiomyogenic potential of human mesenchymal stem cells by modulation of miR expression. 110
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 110
L'età influenza negativamente gli effetti paracrini caridoprotettivi mediati da cellule staminali mesenchimali. 108
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 108
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 108
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 108
Cord blood derived endothelial progenitor cells: a superior buiding company in angiogenesis market. 107
Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta 107
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 107
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 106
Gene and cell-based therapies for heart disease 106
IRES-based lentivirus co-espressing TGFbeta1 and FGF2 improves cell survival and angiogenesis in bone marrow-derived mesenchymal stem cells. 106
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 105
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 105
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 104
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 103
MicroRNA133 and microRNA499 exert synergistic effect on cardiac differentiation 103
Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages 103
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 103
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 103
Enhancing stem cell therapy efficacy through genetic modification 102
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 102
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 102
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 101
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. 101
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 99
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 99
La contemporanea overespressione di miRNA499 e miRNA133 induce il differenziamento in senso cardiomiocitario di cellule staminali pluripotenti. 99
microRNA and Cardiac Regeneration 99
Serum uric acid may modulate the inflammatory response after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction 99
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'? 99
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 98
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 98
Leptin affects the inflammatory response after STEMI 98
Cord blood-derived endothelial progenitor cells: a superior building company in the angiogenesis market: P599 97
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 97
First-in-man case of non-invasive proton radiotherapy for the treatment of refractory ventricular tachycardia in advanced heart failure 96
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell mediated cardiac repair and functional improvement 95
Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction and conditioned media production 95
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 95
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 95
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 94
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 94
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells 93
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 92
Mesenchymal stem cell therapy for heart disease. 91
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 91
Has hyperglycemia a different prognostic role in STEMI patients with or without diabetes? 91
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future 90
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 89
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes 89
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries 88
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 87
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 86
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias 85
The prognostic value of serial troponin measurements in patients admitted for COVID-19 85
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 84
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 83
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart 83
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 82
Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection 81
Endothelium-targeted gene and cell based therapy for cardiovascular disease 81
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 81
Totale 10.854
Categoria #
all - tutte 58.982
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.982


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 0 0 0 0 70 70 20
2021/2022588 6 9 26 7 15 23 9 46 45 16 92 294
2022/20232.151 225 155 37 131 207 211 5 116 950 22 55 37
2023/2024953 99 177 33 62 84 270 33 52 6 40 56 41
2024/20252.482 63 173 37 55 79 148 160 162 625 77 312 591
2025/20265.377 498 429 611 580 760 227 1.044 272 616 340 0 0
Totale 14.477